UHMK1 promotes gastric cancer progression through reprogramming nucleotide metabolism

Journal: The EMBO Journal

Published: 2020-01-23

DOI: 10.15252/embj.2019102541

Affiliations: 16

Authors: 18

Go to article
Institutions Share
Zhongshan Hospital of Xiamen University, China 0.33
Affiliated Hospital of Guilin Medical University, China 0.06
Guangdong Academy of Medical Sciences (Guangdong General Hospital), China 0.06
The First Hospital of China Medical University, China 0.06
Third Affiliated Hospital, HMU, China 0.06
The Second Affiliated Hospital of Harbin Medical University, China 0.06
Beijing Tiantan Hospital, Capital Medical University, China 0.06
First Affiliated Hospital, AHMU, China 0.06
Xiangya School of Medicine, CSU, China 0.06
First Affiliated Hospital, USTC, China 0.06
Yale School of Medicine (YSM), United States of America (USA) 0.03
Duke University Health System, United States of America (USA) 0.03
The First Affiliated Hospital of Harbin Medical University, China 0.03
National Center for International Research of Biological Targeting Diagnosis and Therapy, Guangxi Medical University, China 0.03
Guangxi Provincial Key Laboratory of Biological Targeting Diagnosis and Therapy Research, Guangxi Medical University, China 0.03
Rutgers Robert Wood Johnson Medical School (RWJMS), RU, United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER